Taking BLCA as an example, we found that YTHDF1 was significantly differentially expressed existed in different cancer stages, histological subtypes, patient sex, molecular subtypes, nodal metastasis status and TP53 mutation status of BLCA (Figures 8D–I). This evidence concerns the gene YTHDF1 and bladder transitional cell carcinoma.